Onconetix (ONCO) Market Capitalization (2022 - 2026)

Onconetix (ONCO) has reported Market Capitalization for 5 consecutive years, with $2.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 6.4% year-over-year to $2.5 million in Q2 2026; TTM through Jun 2026 was $2.5 million, a 6.4% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 99.01% from the prior year.
• Market Capitalization was $2.5 million for Q2 2026 at Onconetix, up from $936509.7 in the prior quarter.
• Over five years, Market Capitalization peaked at $1217.8 billion in Q1 2022 and troughed at $936509.7 in Q1 2026.
• A 5-year average of $90.3 billion and a median of $11.6 billion in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization sank 99.98% in 2025 and fell 6.4% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $45.9 billion in 2022, then tumbled by 74.9% to $11.5 billion in 2023, then slumped by 98.72% to $147.0 million in 2024, then plunged by 99.01% to $1.5 million in 2025, then surged by 73.25% to $2.5 million in 2026.
• The last three Market Capitalization figures came in at $2.5 million (Q2 2026), $936509.7 (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.